Valeant Pharmaceuticals International, Inc. (TSE:VRX – Get Free Report) (NYSE:VRX) traded down 3.3% on Monday . The company traded as low as C$30.75 and last traded at C$30.80. 1,232,408 shares traded hands during mid-day trading, a decline of 11% from the average session volume of 1,382,994 shares. The stock had previously closed at C$31.86.
Valeant Pharmaceuticals International Stock Down 3.3 %
The business’s 50 day moving average is C$30.80.
Valeant Pharmaceuticals International Company Profile
Valeant Pharmaceuticals International, Inc operates as a multinational, specialty pharmaceutical, and medical device company that develops, manufactures, and markets a range of pharmaceuticals, over-the-counter (OTC) products, and medical devices. The company operates through three segments: Bausch + Lomb/International, Branded Rx, and U.S.
Featured Stories
- Five stocks we like better than Valeant Pharmaceuticals International
- Short Selling: How to Short a Stock
- United Airlines Soars on Earnings Beat
- What is the NASDAQ Stock Exchange?
- J.B. Hunt Hits the Skids: Lower Prices to Come
- Consumer Discretionary Stocks Explained
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Receive News & Ratings for Valeant Pharmaceuticals International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Valeant Pharmaceuticals International and related companies with MarketBeat.com's FREE daily email newsletter.